📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: BioSim

1.1 - Company Overview

BioSim Logo

BioSim

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of solutions to enable and accelerate drug discovery at quantum accuracy.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to BioSim

Eximia Research Logo

Eximia Research

HQ: United States Website
  • Description: Provider of multi-therapeutic clinical research site network services for biotech companies, conducting Phase I–IV clinical trials across therapeutic and diagnostic indications. Offers patient recruitment and engagement (including underrepresented populations), feasibility studies with investigator feedback, rapid site start-up and feasibility, regulatory and start-up support (contract and budget management), and quality assurance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eximia Research company profile →
BioBridges Logo

BioBridges

HQ: United States Website
  • Description: Provider of flexible expertise, services, and technologies for life sciences companies from discovery through commercialization, offering clinical operations, data management, regulatory affairs, safety & pharmacovigilance, biostatistics, and medical affairs to support studies, compliance, safety, and post-approval lifecycle.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioBridges company profile →
AmbioPharm Logo

AmbioPharm

HQ: United States Website
  • Description: Provider of peptide manufacturing and development services, including GMP and non-GMP custom peptide synthesis via solid phase, solution phase, or hybrid processes. Manufactures active pharmaceutical ingredients and generic peptides, develops research-grade complex peptides, and offers analytical development and validation for HPLC/UPLC, serving pre-clinical, medicinal, and toxicology programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full AmbioPharm company profile →
WCCT Global Logo

WCCT Global

HQ: United States Website
  • Description: Provider of clinical trial services, research sites, and trial support for testing the safety and efficacy of new medications and medical devices, including participant recruitment, screening, and follow-up visits.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full WCCT Global company profile →
3P Biopharmaceuticals Logo

3P Biopharmaceuticals

HQ: Spain Website
  • Description: Provider of biologics and cell therapy development and manufacturing services. Offers comprehensive CDMO support, including process and analytical development, preclinical and clinical supply, and commercial production. Produces proteins via mammalian (CHO, NS0, BHK-21, HEK293, Hybridoma) and microbial (E. coli, P. pastoris, S. cerevisiae, H. pylori, S. noursei) systems, and provides cell therapy technology transfer, process development, cell culture, and GMP certification.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full 3P Biopharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for BioSim

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to BioSim

2.2 - Growth funds investing in similar companies to BioSim

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for BioSim

4.2 - Public trading comparable groups for BioSim

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to BioSim

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About BioSim

What does BioSim do?

BioSim is a provider of solutions to enable and accelerate drug discovery at quantum accuracy.

Who are BioSim's competitors?

BioSim's competitors and similar companies include Eximia Research, BioBridges, AmbioPharm, WCCT Global, and 3P Biopharmaceuticals.

Where is BioSim headquartered?

BioSim is headquartered in United States.

How many employees does BioSim have?

BioSim has 1,000 employees 🔒.

When was BioSim founded?

BioSim was founded in 2010 🔒.

What sector and industry vertical is BioSim in?

BioSim is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for BioSim

Who are the top strategic acquirers in BioSim's sector and industry

Top strategic M&A buyers and acquirers in BioSim's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for BioSim?

Top strategic M&A buyers groups and sectors for BioSim include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in BioSim's sector and industry vertical

Which are the top PE firms investing in BioSim's sector and industry vertical?

Top PE firms investing in BioSim's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in BioSim's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in BioSim's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in BioSim's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to BioSim include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in BioSim's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for BioSim?

The key public trading comparables and valuation benchmarks for BioSim include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for BioSim for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for BioSim with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in BioSim's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for BioSim with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in BioSim's' sector and industry vertical?

Access recent funding rounds and capital raises in BioSim's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for BioSim